CellWell record HH-567697
Risk-adapted intervals for colorectal cancer screening using fecal immunochemical tests: a modelling study based on the BLITZ cohort
Thomas Heisser; Teresa Seum; Michael Hoffmeister; Hermann Brenner
2026
In plain language
Among 6,661 FIT-negative participants, stool hemoglobin levels identified higher-risk subgroups whose cancer detection rates exceeded the low-risk group's 2-year rate after one year, supporting risk-adapted FIT screening intervals.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-567697
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.